BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29588294)

  • 21. [Pituitary apoplexy in giant cell adenoma].
    Ulitin AIu; Oliushin VE; Mel'kishev VF
    Vopr Onkol; 2007; 53(3):339-44. PubMed ID: 18198618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinomas of the pituitary: definition and review of the literature.
    Lübke D; Saeger W
    Gen Diagn Pathol; 1995 Oct; 141(2):81-92. PubMed ID: 8548598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary tumours: pituitary incidentalomas.
    Molitch ME
    Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):667-75. PubMed ID: 19945030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).
    Lenders N; McCormack A
    Pituitary; 2018 Apr; 21(2):217-229. PubMed ID: 29299820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological Findings in the Pituitary Glands of Dogs and Cats.
    Polledo L; Grinwis GCM; Graham P; Dunning M; Baiker K
    Vet Pathol; 2018 Nov; 55(6):880-888. PubMed ID: 29929454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An epidemiological study of hypophyseal adenomas in Aragon and La Rioja].
    Pascual-Piazuelo MC; Bestué M; Serrano-Ponz M; López-Gastón J
    Rev Neurol; 2002 Apr 16-30; 34(8):798-9. PubMed ID: 12080505
    [No Abstract]   [Full Text] [Related]  

  • 27. Demonstration of high coincidence of pituitary adenoma in patients with ruptured Rathke's cleft cyst: Results of a prospective study.
    Ikeda H; Ohhashi G
    Clin Neurol Neurosurg; 2015 Dec; 139():144-51. PubMed ID: 26473987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
    Daly AF; Rixhon M; Adam C; Dempegioti A; Tichomirowa MA; Beckers A
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4769-75. PubMed ID: 16968795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary carcinoma with intraspinal metastasis: report of two cases and review of the literature.
    Wang YQ; Fan T; Zhao XG; Liang C; Qi XL; Li JY
    Int J Clin Exp Pathol; 2015; 8(8):9712-7. PubMed ID: 26464743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pituitary adenoma penetrating the sphenoidal sinus and nasal cavity: a case report].
    Jankiewicz-Wika J; Pawlikowski M; Zawirski M; Stepień H
    Neurol Neurochir Pol; 2001; 35(4):727-32. PubMed ID: 11783414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural course of non-functioning pituitary macroadenomas.
    Dekkers OM; Hammer S; de Keizer RJ; Roelfsema F; Schutte PJ; Smit JW; Romijn JA; Pereira AM
    Eur J Endocrinol; 2007 Feb; 156(2):217-24. PubMed ID: 17287411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant prolactinoma: a rare case report.
    Trivedi P; Gupta A; Pasricha S; Patel D
    Neurol India; 2010; 58(5):778-80. PubMed ID: 21045511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refractory pituitary adenoma: a novel classification for pituitary tumors.
    Dai C; Feng M; Liu X; Ma S; Sun B; Bao X; Yao Y; Deng K; Wang Y; Xing B; Lian W; Zhong D; Ma W; Wang R
    Oncotarget; 2016 Dec; 7(50):83657-83668. PubMed ID: 27845901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
    Bengtsson D; Schrøder HD; Andersen M; Maiter D; Berinder K; Feldt Rasmussen U; Rasmussen ÅK; Johannsson G; Hoybye C; van der Lely AJ; Petersson M; Ragnarsson O; Burman P
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1689-98. PubMed ID: 25646794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of a European registry for pituitary adenomas: the example of Cushing's syndrome registry.
    Webb SM; Santos A; Valassi E
    Ann Endocrinol (Paris); 2012 Apr; 73(2):83-9. PubMed ID: 22541996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas.
    Losa M; Bogazzi F; Cannavo S; Ceccato F; Curtò L; De Marinis L; Iacovazzo D; Lombardi G; Mantovani G; Mazza E; Minniti G; Nizzoli M; Reni M; Scaroni C
    J Neurooncol; 2016 Feb; 126(3):519-25. PubMed ID: 26614517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Null cell adenomas and oncocytomas of the pituitary gland.
    Holm R
    Pathol Res Pract; 1995 May; 191(4):348-52. PubMed ID: 7479351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
    Beckers A; Daly AF
    Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endoscopic treatment of pituitary adenomas].
    Gaillard S; Aqqad A; Aniba K; Foubert L
    Bull Acad Natl Med; 2009 Oct; 193(7):1573-86; discussion 1587-8. PubMed ID: 20669637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
    Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
    J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.